UPDATE: Goldman Sachs Raises PT on Vitamin Shoppe from $56 to $64
Goldman Sachs reiterated a Neutral rating on Vitamin Shoppe (NYSE: VSI) and increased its price target from $56 to $64.
Goldman Sachs wrote, “VSI's 2Q results were marked by improved SSS momentum relative to sector data and peers; nice acceleration in e-commerce sales; and, ongoing operating leverage. SSS are now firmly delivering on the potential associated with rapid unit growth.”
Vitamin Shoppe closed at $60.52 on Tuesday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.